Bio-Rad Laboratories, Inc.

Q3 2025 earnings expected

Quarter

Jul – Sep

Expected

November 14, 2025(ET)

One-time charge this quarter

GAAP is in the red, but excluding a one-time charge of about $403M, Adjusted EPS is $2.26 — core operations remain healthy.

One-time charges include impairment, litigation, and tax events. The score auto-adjusts for these GAAP losses.

Revenue

This quarter$653M

Analyst estimate$652M▲ +0.1%

Year ago (Sep '24)$650M▲ +0.5%

This quarter$2.26

Analyst estimate$1.95▲ +15.7%

Year ago (Sep '24)$2.01▲ +12.4%

+1%YoY

Last 6 quarters · 2 analysts